AbbVie to Host Third-Quarter 2022 Earnings Conference Call
AbbVie (NYSE: ABBV) is set to announce its third-quarter 2022 financial results on October 28, 2022, before market opening.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) is set to announce its third-quarter 2022 financial results on October 28, 2022, before market opening. A live webcast of the earnings call will occur at 8 a.m. CT, accessible through AbbVie's Investor Relations website. An archived version will be available later the same day. AbbVie aims to deliver innovative medicines across various therapeutic areas, addressing serious health issues, including immunology, oncology, and more. For further details, visit the company's official website.
Positive
- AbbVie is scheduled to announce its Q3 2022 financial results, indicating ongoing transparency to investors.
- The live earnings call demonstrates the company's commitment to engaging with shareholders.
Negative
- None.
Details
News Market Reaction – ABBV
The recorded move for ABBV in the trading session of this news was +2.65%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTH CHICAGO, Ill., Oct. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2022 financial results on Friday, October 28, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2022-earnings-conference-call-301639218.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.